Exane Derivatives Progyny, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Progyny, Inc. stock. As of the latest transaction made, Exane Derivatives holds 1,336 shares of PGNY stock, worth $19,412. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,336
Previous 1,336
-0.0%
Holding current value
$19,412
Previous $68,000
44.12%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding PGNY
# of Institutions
308Shares Held
84.5MCall Options Held
157KPut Options Held
115K-
Black Rock Inc. New York, NY11.8MShares$172 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.64MShares$126 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX6.88MShares$99.9 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.43MShares$49.8 Million0.03% of portfolio
-
State Street Corp Boston, MA3.11MShares$45.2 Million0.0% of portfolio
About Progyny, Inc.
- Ticker PGNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 92,080,896
- Market Cap $1.34B
- Description
- Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offe...